Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS

被引：0
|
作者：
Busse, William [1 ]
Castro, Mario [2 ]
Lugogo, Njira [3 ]
O'Byrne, Paul [4 ]
Bacharier, Leonard [5 ]
Xia, Changming [6 ]
Hardin, Megan [7 ]
Soliman, Mena [6 ]
Sacks, Harry [6 ]
Jacob-Nara, Juby [8 ]
Rowe, Paul [8 ]
Deniz, Yamo [6 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Kansas, Sch Med, Kansas City, KS USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Cambridge, MA USA
[8] Sanofi, Bridgewater, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L23
引用
收藏
页码：AB368 / AB368
页数：1
相关论文
共 50 条
  • [31] Dupilumab Suppresses Fractional Exhaled Nitric Oxide (FeNO) and Biomarkers of Type 2 Inflammation in Adult Patients with Persistent Uncontrolled Asthma Despite Use of Medium-to-High Dose Inhaled Corticosteroids Plus LongActing Beta-Agonists (ICS/LABAs)
    Swanson, Brian N.
    Teper, Ariel
    Hamilton, Jennifer D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Tian, Nian
    Wang, Ying
    Ming, Jeffrey E.
    Graham, Neil M. H.
    Pirozzi, Gianluca
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB190 - AB190
  • [32] Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
    Nelson, HS
    Busse, WW
    Kerwin, E
    Church, N
    Emmett, A
    Rickard, K
    Knobil, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (06) : 1088 - 1095
  • [33] Medium-Dose Indacaterol/Glycopyrronium/Mometasone Furoate Fixed-Dose Combination Improves Lung Function Compared with High-Dose Indacaterol/Mometasone Furoate and Salmeterol Fluticasone and Reduces Exacerbation Rates Versus High-Dose Salmeterol/Fluticasone in Moderate-to-Severe Asthma: The IRIDIUM Study
    Papi, A.
    Humbert, M.
    Kostikas, K.
    Domingo, C.
    Maspero, J. F.
    Hosoe, M.
    Tanase, A.
    Pethe, A.
    Shu, X.
    D'Andrea, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study
    Ohbayashi, Hiroyuki
    Hozawa, Soichiro
    Bertran, Alexandra
    Yoshisue, Hajime
    Tanaka, Hiroshi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (07) : 656 - 667
  • [35] Tiotropium Respimat® Add-On Therapy To Inhaled Corticosteroids (ics) plus Long-Acting β2-Agonists (labas) In Patients With Symptomatic Severe Asthma: Efficacy By Level Of Airway Obstruction
    Kerstjens, H. A. M.
    Engel, M.
    Dahl, R.
    Paggiaro, P.
    Beck, E.
    Vandewalker, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Bateman, E. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] TIOTROPIUM RESPIMAT® ADD-ON THERAPY TO INHALED CORTICOSTEROIDS (ICS) plus LONG-ACTING β2-AGONISTS (LABAS) IN PATIENTS WITH SYMPTOMATIC SEVERE ASTHMA: EFFICACY BY LEVEL OF AIRWAY OBSTRUCTION
    Frith, P.
    Kerstjens, H.
    Engel, M.
    Dahl, R.
    Paggiaro, P.
    Beck, E.
    Vandewalker, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Bateman, E.
    RESPIROLOGY, 2016, 21 : 107 - 107
  • [37] Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations and improved outcomes; A Randomized controlled trial
    Mannan, S. E.
    Yousef, E.
    McGeady, S. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S219 - S219
  • [38] Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations and improved outcomes; A randomized controlled trial
    Skorpinski, EW
    Yousef, E
    McGeady, SJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S93 - S93
  • [39] Double-blind study of inhaled salbutamol versus salbutamol plus high-dose flunisolide in exacerbation of bronchial asthma: A pilot study
    LaRosa, M
    Ranno, C
    Mandara, G
    Barbato, A
    Biraghi, M
    PEDIATRIC ASTHMA ALLERGY & IMMUNOLOGY, 1997, 11 (01) : 23 - 30
  • [40] Burden of Persistent Asthma in Patients Treated With Medium- to High-Dose Inhaled Corticosteroids: Baseline Data From a Phase 2 Clinical Trial of Dupilumab
    Corren, Jonathan
    Castro, Mario
    Joish, Vijay
    Mastey, Vera
    Amand, Caroline
    Taniou, Christine
    Evans, Robert
    Tisserand, Mariana Louis
    Teper, Ariel
    Eckert, Laurent
    CHEST, 2015, 148 (04)
12345